GlassScriptPhysician profile
Latrice M Allen
NPI 1639118359
$5,358.90
in general payments reported to CMS, 2019-2025
42 companies · $588 in 2025
The $588 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $867 · 2020: $418 · 2021: $860 · 2022: $837 · 2023: $956 · 2024: $833 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,376.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $948.66 | 2019-2025 | Liletta |
| Organon LLC | $460.32 | 2021-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $409.67 | 2021-2025 | |
| Sage Therapeutics, LLC | $360.44 | 2019-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $278.12 | 2019-2025 | |
| Agile Therapeutics, INC. | $243.38 | 2021-2024 | Twirla |
| Exeltis, USA INC. | $220.34 | 2020-2025 | Slynd |
| Hologic Sales and Service, LLC | $175.82 | 2019-2023 | Acessa Provu System |
| Becton, Dickinson and Company | $158.77 | 2019-2023 | Bd Onclarity |
| Myovant Sciences INC. | $158.68 | 2021-2022 | |
| Aspira Women'S Health INC | $154.79 | 2019-2024 | Ova1 |
| Astellas Pharma US INC | $152.57 | 2020-2024 | Veozah |
| Avion Pharmaceuticals | $152.28 | 2019-2023 | Balcoltra |
| Sumitomo Pharma America, INC. | $141.63 | 2023-2025 | Myfembree |
| Evofem Biosciences, INC. | $137.59 | 2021-2025 | Phexxi, Solosec, Phexx |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Latrice Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.